BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

845 related articles for article (PubMed ID: 19595306)

  • 1. PI3K/PTEN signaling in angiogenesis and tumorigenesis.
    Jiang BH; Liu LZ
    Adv Cancer Res; 2009; 102():19-65. PubMed ID: 19595306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PTEN regulates angiogenesis through PI3K/Akt/VEGF signaling pathway in human pancreatic cancer cells.
    Ma J; Sawai H; Ochi N; Matsuo Y; Xu D; Yasuda A; Takahashi H; Wakasugi T; Takeyama H
    Mol Cell Biochem; 2009 Nov; 331(1-2):161-71. PubMed ID: 19437103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PI3K/PTEN signaling in tumorigenesis and angiogenesis.
    Jiang BH; Liu LZ
    Biochim Biophys Acta; 2008 Jan; 1784(1):150-8. PubMed ID: 17964232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PI3K/PTEN/AKT signaling regulates prostate tumor angiogenesis.
    Fang J; Ding M; Yang L; Liu LZ; Jiang BH
    Cell Signal; 2007 Dec; 19(12):2487-97. PubMed ID: 17826033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Repression of microRNA-21 inhibits retinal vascular endothelial cell growth and angiogenesis via PTEN dependent-PI3K/Akt/VEGF signaling pathway in diabetic retinopathy.
    Lu JM; Zhang ZZ; Ma X; Fang SF; Qin XH
    Exp Eye Res; 2020 Jan; 190():107886. PubMed ID: 31759996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A macrophage-dominant PI3K isoform controls hypoxia-induced HIF1α and HIF2α stability and tumor growth, angiogenesis, and metastasis.
    Joshi S; Singh AR; Zulcic M; Durden DL
    Mol Cancer Res; 2014 Oct; 12(10):1520-31. PubMed ID: 25103499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of Mel-18 induces tumor angiogenesis through enhancing the activity and expression of HIF-1α mediated by the PTEN/PI3K/Akt pathway.
    Park JH; Lee JY; Shin DH; Jang KS; Kim HJ; Kong G
    Oncogene; 2011 Nov; 30(45):4578-89. PubMed ID: 21602890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Astragaloside IV exerts angiogenesis and cardioprotection after myocardial infarction via regulating PTEN/PI3K/Akt signaling pathway.
    Cheng S; Zhang X; Feng Q; Chen J; Shen L; Yu P; Yang L; Chen D; Zhang H; Sun W; Chen X
    Life Sci; 2019 Jun; 227():82-93. PubMed ID: 31004658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apoptosis regulator through modulating IAP expression (ARIA) controls the PI3K/Akt pathway in endothelial and endothelial progenitor cells.
    Koide M; Ikeda K; Akakabe Y; Kitamura Y; Ueyama T; Matoba S; Yamada H; Okigaki M; Matsubara H
    Proc Natl Acad Sci U S A; 2011 Jun; 108(23):9472-7. PubMed ID: 21593423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The PTEN⁻PI3K Axis in Cancer.
    Papa A; Pandolfi PP
    Biomolecules; 2019 Apr; 9(4):. PubMed ID: 30999672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interplay Among PI3K/AKT, PTEN/FOXO and AR Signaling in Prostate Cancer.
    Yan Y; Huang H
    Adv Exp Med Biol; 2019; 1210():319-331. PubMed ID: 31900915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular neuro-oncology and development of targeted therapeutic strategies for brain tumors. Part 2: PI3K/Akt/PTEN, mTOR, SHH/PTCH and angiogenesis.
    Newton HB
    Expert Rev Anticancer Ther; 2004 Feb; 4(1):105-28. PubMed ID: 14748662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antitumor effect of a selective COX-2 inhibitor, celecoxib, may be attributed to angiogenesis inhibition through modulating the PTEN/PI3K/Akt/HIF-1 pathway in an H₂₂ murine hepatocarcinoma model.
    Sui W; Zhang Y; Wang Z; Wang Z; Jia Q; Wu L; Zhang W
    Oncol Rep; 2014 May; 31(5):2252-60. PubMed ID: 24647425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PTEN signaling in brain: neuropathology and tumorigenesis.
    Endersby R; Baker SJ
    Oncogene; 2008 Sep; 27(41):5416-30. PubMed ID: 18794877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Roles of the RAF/MEK/ERK and PI3K/PTEN/AKT pathways in malignant transformation and drug resistance.
    McCubrey JA; Steelman LS; Abrams SL; Lee JT; Chang F; Bertrand FE; Navolanic PM; Terrian DM; Franklin RA; D'Assoro AB; Salisbury JL; Mazzarino MC; Stivala F; Libra M
    Adv Enzyme Regul; 2006; 46():249-79. PubMed ID: 16854453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PTEN/PI3K/Akt/VEGF signaling and the cross talk to KRIT1, CCM2, and PDCD10 proteins in cerebral cavernous malformations.
    Kar S; Samii A; Bertalanffy H
    Neurosurg Rev; 2015 Apr; 38(2):229-36; discussion 236-7. PubMed ID: 25403688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PTEN regulates angiogenesis and VEGF expression through phosphatase-dependent and -independent mechanisms in HepG2 cells.
    Tian T; Nan KJ; Wang SH; Liang X; Lu CX; Guo H; Wang WJ; Ruan ZP
    Carcinogenesis; 2010 Jul; 31(7):1211-9. PubMed ID: 20430845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of PI3K/AKT/FOXO signaling in psoriasis.
    Zhang M; Zhang X
    Arch Dermatol Res; 2019 Mar; 311(2):83-91. PubMed ID: 30483877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PI3K/AKT Pathway and Its Mediators in Thyroid Carcinomas.
    Nozhat Z; Hedayati M
    Mol Diagn Ther; 2016 Feb; 20(1):13-26. PubMed ID: 26597586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of hypoxia-inducible factor 1alpha expression by the epidermal growth factor/phosphatidylinositol 3-kinase/PTEN/AKT/FRAP pathway in human prostate cancer cells: implications for tumor angiogenesis and therapeutics.
    Zhong H; Chiles K; Feldser D; Laughner E; Hanrahan C; Georgescu MM; Simons JW; Semenza GL
    Cancer Res; 2000 Mar; 60(6):1541-5. PubMed ID: 10749120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 43.